Bausch Health Companies Inc (BHC)

[maseraticoupe]

Valeant to present at the Goldman Sachs Conference. June 20

LAVAL, Quebec, May 31, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Paul Herendeen, executive vice president and chief financial officer, and Linda LaGorga, senior vice president, finance and treasurer, are scheduled to present at the following financial Conferences Goldman Sachs Second Annual Leveraged Finance Conference on Tuesday, June 20, 2017 at 10:40 a.m. PDT (1:40 p.m. EDT) at Terranea, Rancho Palos Verde, Calif. A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/events-and-presentations About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at www.valeant.com. Contact Information Investors: Elif McDonald [e-mail] 514-856-3855 877-281-6642 (toll free) Media: Lainie Keller [e-mail] 908-927-0617 Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.) (PRNewsFoto/) To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-present-at-financial-industry-conferences-300466400.html SOURCE Valeant Pharmaceuticals International, Inc.